Search - tctmd.com

Displaying 21 - 40 of 1293

Sort: Relevancy | Date

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

Presentation TCT 2025

TCT 1760: Left Main and LAD Severely Calcified Last Remaining Vessel Protected PCI in Low EF and Severe PAD: Many Tasks All at a Time

Presenter: Anita Paggi

October 25, 2025

Presentation TCT 2025

TCT 1397: Peripheral Arterial Disease (PAD) and TAVR: Roadblock Management

Presenter: Kevin Tijerina Flores

October 25, 2025

News Daily News

Pregnancy-Related CV Complications on the Rise

Todd Neale

October 09, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2025

Michael O'Riordan

September 30, 2025

News Daily News

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

L.A. McKeown

September 22, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

Podcast Heart Sounds

Top Cardiology News for June 2025

June 25, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

Presentation Fellows 2025

Workup and Treatment of Lower-Extremity PAD: What All Interventionalists Need to Know

Presenter: Sahil A. Parikh

May 18, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Conference News CRT 2025

ATTENUATE: Protective Drape Cuts Operator Radiation Dose Across Interventions

L.A. McKeown

March 14, 2025

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

News Daily News

Survey Calls Out Implicit Bias in Peripheral Vascular Care

L.A. McKeown

February 28, 2025

Podcast Heart Sounds

Top Cardiology News for February 2025

February 26, 2025

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

L.A. McKeown

February 13, 2025

Advertisement

October 2025 Dispatch for the CV Team

TCT 1760: Left Main and LAD Severely Calcified Last Remaining Vessel Protected PCI in Low EF and Severe PAD: Many Tasks All at a Time

TCT 1397: Peripheral Arterial Disease (PAD) and TAVR: Roadblock Management

Pregnancy-Related CV Complications on the Rise

TCTMD’s Top 10 Most Popular Stories for September 2025

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Top Cardiology News for June 2025

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

Workup and Treatment of Lower-Extremity PAD: What All Interventionalists Need to Know

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

ATTENUATE: Protective Drape Cuts Operator Radiation Dose Across Interventions

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Survey Calls Out Implicit Bias in Peripheral Vascular Care

Top Cardiology News for February 2025

AHA Scientific Statement Takes Aim at PAD Pain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content